Bronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy Adults

Voriconazole and anidulafungin in combination are being investigated for use for the treatment of pulmonary aspergillosis. We determined the pulmonary disposition of these agents. Twenty healthy participants received intravenous voriconazole (at 6 mg/kg of body weight every 12 h [q12h] on day 1 and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Crandon, Jared L., Banevicius, Mary Anne, Fang, Annie F., Crownover, Penelope H., Knauft, R. Fredrick, Pope, J. Samuel, Russomanno, John H., Shore, Eric, Nicolau, David P., Kuti, Joseph L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2009
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2786330/
https://ncbi.nlm.nih.gov/pubmed/19770284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01042-09
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller